FDA's Tobacco Product Center (CTP) Strategic Planning: Public Hearing

Aug.22.2023
FDA's Tobacco Product Center (CTP) Strategic Planning: Public Hearing
The US FDA's Center for Tobacco Products (CTP) is developing a five-year strategic plan to reduce tobacco-related deaths and diseases.

The U.S. Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) is formulating a five-year strategic plan to advance its mission of reducing tobacco-related deaths and illnesses. Through a comprehensive, center-wide approach, CTP has identified five proposed areas of focus, which were shaped by input from employees and leaders within the center. These areas of focus are intended to intersect with four cross-cutting themes: health equity, science, transparency, and stakeholder engagement.


In order to encourage public participation, the CTP hosted an online public hearing on August 22, 2023 at 10 pm Beijing time (10 am local time). This event provided the public with an opportunity to orally comment on the development of the five-year strategic plan and proposed strategic goals. Following an introduction, the organization presented an overview of the process used to develop the CTP strategic plan and proposed goals. Registered speakers were then given approximately 4 minutes each to verbally share their thoughts on the strategic plan.


As CTP develops its strategic plan, the organization is actively seeking public opinions on both the proposed target areas as well as other areas not currently covered by these goals. CTP encourages the submission of forward-thinking, constructive, and concise comments, addressing the following questions:


What key characteristics, activities, or initiatives do you hope CTP will consider in these proposed target areas? For example, in terms of regulations and guidance documents, what specific regulations and guidance documents do you believe FDA should pursue and how should these documents be prioritized? What are the measurable short-term and long-term outcomes in the proposed target areas over the next 2 to 5 years? What three specific measures do you believe CTP can take in the next five years that will have the greatest impact on significantly reducing tobacco-related deaths and illnesses? Do you believe there are important characteristics, activities, or initiatives that CTP should consider as part of its strategic plan that are not currently covered by these proposed target areas?


The hearing is being held to gather public opinions, as the CTP plans to release its final strategic plan by the end of 2023. Each speaker at the hearing has a time limit of 4 minutes. If you have any comments regarding the four questions mentioned above, please scan the QR code below or leave a message here.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

New Movement Emerges on EU Tobacco Excise Directive as Cyprus Tables Compromise Draft
New Movement Emerges on EU Tobacco Excise Directive as Cyprus Tables Compromise Draft
The long-stalled debate over the European Union’s Tobacco Excise Directive may be moving forward, with Cyprus, as holder of the EU Council presidency, putting forward a compromise draft. The reported proposal includes lowering the minimum excise duty requirement and granting a transitional period, with the aim of reaching political agreement by June 2026. The revision also covers e-cigarettes, heated tobacco, nicotine pouches and stronger controls on raw tobacco.
Apr.21 by 2FIRSTS.ai
BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
According to Investing.com citing Bank of America scanner data for the four weeks ending May 30, U.S. nicotine category performance was mixed, with cigarette, vapor and cigar sales declining while oral tobacco sales rose 5.8%.
Jun.10
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea said on April 29 that it has appointed Lee Hong-seok, head of its smoke-free products division, as its new chief executive officer, with his term beginning on May 1. Yoon Hee-kyung, who took office in 2023, will step down after about three years in the role.
Apr.30 by 2FIRSTS.ai
Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesia’s Ministry of Health is preparing to implement regulations on electronic cigarettes, as provided for in Government Regulation No. 28 of 2024. The ministry said e-cigarettes will be regulated under provisions equivalent to those applied to conventional cigarettes, including age restrictions, advertising controls, product content standards, pictorial health warnings, and bans on use in smoke-free areas.
Apr.16 by 2FIRSTS.ai
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea’s Ministry of Finance and Economy said on May 4 that it requested the Daejeon Metropolitan Police Agency and Gyeonggi Nambu Provincial Police Agency to investigate three sales companies on suspicion of violating the Tobacco Business Act.
May.06 by 2FIRSTS.ai
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17